Literature DB >> 17699225

Early arteriovenous fistula failure: a logical proposal for when and how to intervene.

Arif Asif1, Prabir Roy-Chaudhury, Gerald A Beathard.   

Abstract

A significant number of arteriovenous fistulae (28 to 53%) never mature to support dialysis. Often, renal physicians and surgeons wait for up to 6 months and even longer hoping that the arteriovenous fistula (AVF) will eventually grow to support dialysis before declaring that the AVF has failed. In the interim, if dialysis is needed, then a tunneled catheter is inserted, exposing the patient to the morbidity and mortality associated with the use of this device. In general, a blood flow of 500 ml/min and a diameter of at least 4 mm are needed for an AVF to be adequate to support dialysis therapy. In most successful fistulae, these parameters are met within 4 to 6 wk. Most important, commonly encountered problems (stenosis and accessory veins) that result in early AVF failure can be diagnosed easily with skillful physical examination. Recent studies have indicated that a great majority of fistulae that have failed to mature adequately can be salvaged by percutaneous interventions and become available for dialysis. Early intervention regarding identification and salvage of a nonmaturing AVF is critical for several reasons. First, an AVF is the best available type of access regarding complications, costs, morbidity, and mortality. Second, this approach minimizes catheter use and its associated complications. Finally, access stenosis is a progressive process and eventually culminates in complete occlusion, leading to access thrombosis. In this context, the opportunity to salvage the AVF that fails early may be lost. This report reviews the process of AVF maturation and suggests a strategy for when and how to intervene to identify and salvage AVF with early failure.

Entities:  

Mesh:

Year:  2005        PMID: 17699225     DOI: 10.2215/CJN.00850805

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  51 in total

1.  Origin of neointimal cells in arteriovenous fistulae: bone marrow, artery, or the vein itself?

Authors:  Nikolaos Skartsis; Eddie Manning; Yuntao Wei; Omaida C Velazquez; Zhao-Jun Liu; Pascal J Goldschmidt-Clermont; Loay H Salman; Arif Asif; Roberto I Vazquez-Padron
Journal:  Semin Dial       Date:  2011 Mar-Apr       Impact factor: 3.455

2.  Improved cumulative survival in fistulas requiring surgical interventions to promote fistula maturation compared with endovascular interventions.

Authors:  Timmy Lee; Arshdeep Tindni; Prabir Roy-Chaudhury
Journal:  Semin Dial       Date:  2012-03-09       Impact factor: 3.455

3.  We Need to Train the Trainers.

Authors:  Arif Asif; Gerald A Beathard
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-25       Impact factor: 8.237

4.  Dialysis Arteriovenous Fistula Failure and Angioplasty: Intimal Hyperplasia and Other Causes of Access Failure.

Authors:  Juan C Duque; Marwan Tabbara; Laisel Martinez; Jose Cardona; Roberto I Vazquez-Padron; Loay H Salman
Journal:  Am J Kidney Dis       Date:  2016-10-27       Impact factor: 8.860

Review 5.  Novel paradigms for dialysis vascular access: downstream vascular biology--is there a final common pathway?

Authors:  Timmy Lee
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

6.  Unanticipated late maturation of an arteriovenous fistula after creation of separate graft access.

Authors:  Hanzhou Li; Serena Jen; Tarun Ramayya; H Gregory Bowers; Eran Rotem
Journal:  Quant Imaging Med Surg       Date:  2018-05

Review 7.  Definitions and End Points for Interventional Studies for Arteriovenous Dialysis Access.

Authors:  Gerald A Beathard; Charmaine E Lok; Marc H Glickman; Ahmed A Al-Jaishi; Donna Bednarski; David L Cull; Jeffery H Lawson; Timmy C Lee; Vandana D Niyyar; Donna Syracuse; Scott O Trerotola; Prabir Roy-Chaudhury; Surendra Shenoy; Margo Underwood; Haimanot Wasse; Karen Woo; Theodore H Yuo; Thomas S Huber
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

Review 8.  Vein graft adaptation and fistula maturation in the arterial environment.

Authors:  Daniel Y Lu; Elizabeth Y Chen; Daniel J Wong; Kota Yamamoto; Clinton D Protack; Willis T Williams; Roland Assi; Michael R Hall; Nirvana Sadaghianloo; Alan Dardik
Journal:  J Surg Res       Date:  2014-01-30       Impact factor: 2.192

9.  Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients.

Authors:  A Ghorbani; M Aalamshah; H Shahbazian; A Ehsanpour; A Aref
Journal:  Indian J Nephrol       Date:  2009-04

10.  Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Authors:  Ashley Irish; Gursharan Dogra; Trevor Mori; Elaine Beller; Stephane Heritier; Carmel Hawley; Peter Kerr; Amanda Robertson; Johan Rosman; Peta-Anne Paul-Brent; Melissa Starfield; Kevan Polkinghorne; Alan Cass
Journal:  BMC Nephrol       Date:  2009-01-21       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.